Depression
Feature
Benefits of bremelanotide to women with HSDD questioned in analysis paper
Author of paper criticized reacts to analysis of bremelanotide data.
From the Journals
Novel therapeutic target for depression identified
Previous research using a chronic social defeat model of depression in mice showed changes in the KCNQ2/3 channel.
Feature
How to make resident mental health care stigma free
Opt-out programs offer a counterbalance to many negative tendencies in residency, said Dr. Lisa Meeks.
News from the FDA/CDC
U.S. suicide rate in 2019 took first downturn in 14 years
As the response to the COVID-19 pandemic continues, the investigators pointed out, "prevention is more important than ever."
Conference Coverage
Severe atopic dermatitis often puts a dent in quality of life
“There have been many surveys of adults with AD who report impairment of their sleep, reduced activity level, increased work absence, financial...
Conference Coverage
Mepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbidities
Few studies have examined the efficacy of mepolizumab therapy for patients with asthma and comorbidities.
From the Journals
PTSD prevalent in survivors of severe COVID-19
The results are “in line” with findings reported in other events, such as Hurricane Katrina of 2005, and the 2011 Japan earthquake and tsunami.
Commentary
Heroes: Nurses’ sacrifice in the age of COVID-19
“Imagine spending an entire year laboring through the heavy task of lifting patients to prone them in a position that may save their lives,” said...
Conference Coverage
Inflammatory immune findings likely in acute schizophrenia, MDD, bipolar
“Some of this activation decreases with effective acute treatment of the disorder,” said Dr. Mark Hyman Rapaport.
Conference Coverage
Consider connections between depression, chronic medical comorbidities
“We want to collaborate closely and regularly with other treaters, sharing our notes and diagnostic impressions,” Dr. Jonathan E. Alpert said.
From the Journals
Antidepressants may scupper efficacy of MDMA for PTSD
The findings have implications for clinical practice if MDMA-assisted psychotherapy is approved by the FDA, said Dr. Allison Feduccia.